3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
2
Status
Unknown
2
Withdrawn
1
Terminated
1
Completed
1
Active not recruiting
1
Sponsor Class
OTHER
2
Study Type
Interventional
2
Sponsor
Cancer Type
Breast
2
Genitourinary
1
Gastrointestinal
1
Conditions
Neoplasms
3
Motor Activity
3
Breast Neoplasms
2
Prostatic Neoplasms
1
Inflammation
1
Fatigue
1
Colorectal Neoplasms
1
Chemotherapy-Related Cognitive Impairment
1
Cachexia
1
Interventions
Cyclophosphamide
76
Docetaxel
69
Capecitabine
64
Trastuzumab
61
Paclitaxel
50
Tamoxifen
46
Epirubicin
46
Letrozole
42
pyrotinib
40
Fulvestrant
36
Doxorubicin
35
Vinorelbine
33
Radiotherapy
32
Carboplatin
31
exemestane
27
Anastrozole
27
Neoadjuvant Therapy
24
Drug Therapy
22
Fluorouracil
21
palbociclib
20
Exercise
19
Chemotherapy, Adjuvant
19
Bevacizumab
18
pertuzumab
16
Goserelin
16
Cisplatin
16
liposomal doxorubicin
15
Mammography
14
Gemcitabine
14
Blood Specimen Collection
14
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Unknown
×
Breast Neoplasms
×
High-Intensity Interval Training
×
Clear all
NCT02473003
2023-12-21
Phys-Can
Uppsala University
Phase NA
Unknown
600 enrolled
NCT04789187
2021-03-12
ECCO
Johannes Kepler University of Linz
Phase NA
Unknown
126 enrolled